Tofersen Biogen - Search Images

1920×1080
cnbc.com
Biogen falls after Alzheimer’s drug approval. What the pros are saying
1920×1080
clinicaltrialsarena.com
Biogen’s tofersen fails to meet primary goal in Phase III ALS trial
800×600
pharmaceutical-technology.com
FDA grants priority review for Biogen’s tofersen to treat ALS
1024×1024
abingtonneurology.com
FDA Gives Accelerated Approval to New ALS T…

1024×512
lifesciences.csoftintl.com
Biogen Strives for Tofersen Approval in ALS Based on Neurofilament ...
2048×1152
endpts.com
Despite a PhIII fail, Biogen pushes ALS drug tofersen forward with new ...
474×315
bloomberg.com
Biogen’s ALS Drug Tofersen Gets Partial Backing From FDA Pane…
480×320
als.org
FAQ: Biogen is Now Enrolling in Phase 3 VALOR Clinical Trial to …

850×566
seekingalpha.com
Biogen Hits A Wall, What's Next? (NASDAQ:BIIB) | Seeking Alpha
801×399
generiscorp.com
Biogen - Generis
1920×1080
axios.com
Biogen faces patent loss for lucrative MS drug
2400×1800
businessinsider.com
Biogen Q2 2017 earnings - Business Insider

Some results have been hidden because they may be inaccessible to you.Show inaccessible results